相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA
Manu Thomas Kalathottukaren et al.
BLOOD (2017)
Construction and characterisation of a heparan sulphate heptasaccharide microarray
Jianhong Yang et al.
CHEMICAL COMMUNICATIONS (2017)
The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles
Joanna S. Said et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The sweet spot: how GAGs help chemokines guide migrating cells
Yoan Monneau et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Expanding the 3-O-Sulfate Proteome-Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity
Bryan E. Thacker et al.
ACS CHEMICAL BIOLOGY (2016)
Reversal agents for use with direct and indirect anticoagulants
Maureen A. Smythe et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides
Rongrong Huang et al.
ANALYTICAL CHEMISTRY (2016)
The toxicology of heparin reversal with protamine: past, present and future
Emilia Sokolowska et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin
Jack E. Ansell et al.
THROMBOSIS RESEARCH (2016)
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples
Boris Winterhoff et al.
EUROPEAN JOURNAL OF CANCER (2015)
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?
Antonio Gnoni et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Divergent Synthesis of Heparan Sulfate Oligosaccharides
Steven B. Dulaney et al.
JOURNAL OF ORGANIC CHEMISTRY (2015)
Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells
Hooi Ching Lim et al.
MOLECULAR CANCER (2015)
Small molecule antagonists of cell-surface heparan sulfate and heparin-protein interactions
Ryan J. Weiss et al.
CHEMICAL SCIENCE (2015)
Inhibition of influenza H5N1 invasion by modified heparin derivatives
Mark A. Skidmore et al.
MEDCHEMCOMM (2015)
Expression of the Heparan Sulfate 6-O-endosulfatases, Sulf1 and Sulf2, in the Avian and Mammalian Inner Ear Suggests a Role for Sulfation during Inner Ear Development
Stephen D. Freeman et al.
DEVELOPMENTAL DYNAMICS (2015)
De Novo Design of Self-Assembling Foldamers That Inhibit Heparin-Protein Interactions
Geronda L. Montalvo et al.
ACS CHEMICAL BIOLOGY (2014)
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments
Anna Alekseeva et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Demystifying Heparan Sulfate-Protein Interactions
Ding Xu et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Murine T cell activation is regulated by surfen (bis-2-methyl-4-amino-quinolyl-6-carbamide)
Jordan Warford et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties
Nicholas Harris et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Reducing Macrophage Proteoglycan Sulfation Increases Atherosclerosis and Obesity through Enhanced Type I Interferon Signaling
Philip L. S. M. Gordts et al.
CELL METABOLISM (2014)
Heparan Sulfate Proteoglycans and Human Breast Cancer Epithelial Cell Tumorigenicity
Rachel K. Okolicsanyi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-κB signaling
Hasan Babazada et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Low molecular weight protamine (LMWP): A nontoxic protamine substitute and an effective cell-penetrating peptide
Huining He et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Surfen, a proteoglycan antagonist, reduces lysolecithin-induced demyelination with related effects on macrophage function
Lordan Warford et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents
Charles E. Mahan
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans
Che C. Colpitts et al.
JOURNAL OF VIROLOGY (2014)
A Computational Framework for Heparan Sulfate Sequencing Using High-resolution Tandem Mass Spectra
Han Hu et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Chemoenzymatic synthesis of heparan sulfate and heparin
Jian Liu et al.
NATURAL PRODUCT REPORTS (2014)
Heparan sulfate in the nucleus and its control of cellular functions
Mark D. Stewart et al.
MATRIX BIOLOGY (2014)
Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants
Rajesh A. Shenoi et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Heparan sulfate signaling in cancer
Erik H. Knelson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
New arginine substituted derivative of poly(allylamine hydrochloride) for heparin reversal
Kamil Kaminski et al.
MEDCHEMCOMM (2014)
Tailored Design and Synthesis of Heparan Sulfate Oligosaccharide Analogues Using Sequential One-Pot Multienzyme Systems
Yi Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
A Peptide Inhibitor of Cytomegalovirus Infection from Human Hemofiltrate
Eva Maria Borst et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The accumulation of circulating histones on heparan sulphate in the capillary glycocalyx of the lungs
Craig G. Freeman et al.
BIOMATERIALS (2013)
Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection
J. H. Kim et al.
CELLULAR MICROBIOLOGY (2013)
Heparin sensing and binding - taking supramolecular chemistry towards clinical applications
Stephen M. Bromfield et al.
CHEMICAL SOCIETY REVIEWS (2013)
Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: A mechanism likely deranged in Hereditary Multiple Exostoses
Julianne Huegel et al.
DEVELOPMENTAL BIOLOGY (2013)
Heparan sulfate in skeletal development, growth, and pathology: The case of hereditary multiple exostoses
Julianne Huegel et al.
DEVELOPMENTAL DYNAMICS (2013)
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
Jon C. Gonzales et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Pathophysiology of heparan sulphate: many diseases, few drugs
U. Lindahl et al.
JOURNAL OF INTERNAL MEDICINE (2013)
A chemically-modified inactive antithrombin as a potent antagonist of fondaparinux and heparin anticoagulant activity
J. Fazavana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Brandon B. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study
Esmail M. EL-Fakharany et al.
VIROLOGY JOURNAL (2013)
Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition
Bridgette J. Connell et al.
FRONTIERS IN IMMUNOLOGY (2013)
The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors
Tunde Szatmari et al.
FRONTIERS IN ONCOLOGY (2013)
Top-Down Approach for the Direct Characterization of Low Molecular Weight Heparins Using LC-FT-MS
Lingyun Li et al.
ANALYTICAL CHEMISTRY (2012)
Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation
Stephanie A. Smith et al.
BLOOD (2012)
Array-Based Functional Screening of Heparin Glycans
Tania M. Puvirajesinghe et al.
CHEMISTRY & BIOLOGY (2012)
Heparan Sulfate Dissociates Serum Amyloid A (SAA) from Acute-phase High-density Lipoprotein, Promoting SAA Aggregation
Fredrik Noborn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis
Vito Ferro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Cell Membrane-associated Heparan Sulfate Is a Receptor for Prototype Foamy Virus in Human, Monkey, and Rodent Cells
Md Nasimuzzaman et al.
MOLECULAR THERAPY (2012)
Fondaparinux - data on efficacy and safety in special situations
Michael Nagler et al.
THROMBOSIS RESEARCH (2012)
Protamine neutralisation of low molecular weight heparins and their oligosaccharide components
Mette Schroeder et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Self-Assembling Ligands for Multivalent Nanoscale Heparin Binding
Ana C. Rodrigo et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Inhibition of Herpes Simplex Virus Type 1 and Type 2 Infections by Peptide-Derivatized Dendrimers
Anna Luganini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection
Dianne Marais et al.
ANTIVIRAL THERAPY (2011)
Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives
Elsa P. Bianchini et al.
BLOOD (2011)
Protamine reversal of low molecular weight heparin: clinically effective?
Joost J. van Veen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones
Beverly M. Zak et al.
BONE (2011)
Heparan Sulfate Regulates VEGF165- and VEGF121-mediated Vascular Hyperpermeability*
Ding Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid-β Uptake
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2011)
Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction
Yu-Peng Hu et al.
NATURE CHEMISTRY (2011)
Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Yongmei Xu et al.
SCIENCE (2011)
Heparan Sulfate Proteoglycans
Stephane Sarrazin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling
Felix S. Gruenewald et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
In Vivo Neutralization of Unfractionated Heparin and Low-Molecular-Weight Heparin by a Novel Salicylamide Derivative
Jacqueline Kuziej et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2010)
Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications
Allison H. Bartlett et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
K. Dredge et al.
INVESTIGATIONAL NEW DRUGS (2010)
Aminoquinoline Surfen Inhibits the Action of SEVI (Semen-derived Enhancer of Viral Infection)
Nadia R. Roan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Chemoenzymatic Design of Heparan Sulfate Oligosaccharides
Renpeng Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types
Tatevik R. Broutian et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer
Benito Casu et al.
MATRIX BIOLOGY (2010)
Polycationic calix[8]arene receptors grafted onto polymeric matrix: smart material for heparin neutralization
Tommaso Mecca et al.
POLYMERS FOR ADVANCED TECHNOLOGIES (2010)
Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways
Shuhei Otsuki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Heparin-antagonist PMX-60056 rapidly and completely reverses heparin anticoagulation in man
R. E. McAllister
THROMBOSIS RESEARCH (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study
Dominik Krilleke et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Heparin Antagonism by Polyvalent Display of Cationic Motifs on Virus-Like Particles
Andrew K. Udit et al.
CHEMBIOCHEM (2009)
Rapid Purification and High Sensitivity Analysis of Heparan Sulfate from Cells and Tissues TOWARD GLYCOMICS PROFILING
Scott E. Guimond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
Chun-Jen Liu et al.
JOURNAL OF HEPATOLOGY (2009)
Modular Synthesis of Heparan Sulfate Oligosaccharides for Structure-Activity Relationship Studies
Sailaja Arungundram et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
The Effect of LMWH (Nadroparin) on Tumor Progression
Zsuzsanna Nagy et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides
Marco Rusnati et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1
Ronald Copeland et al.
BIOCHEMISTRY (2008)
Heparin-induced thrombocytopenia: a historical perspective
John G. Kelton et al.
BLOOD (2008)
The story of the discovery of heparin and warfarin
Douglas Wardrop et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Heparin as an anticancer therapeutic
Leo R. Zacharski et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
PI-88: a novel inhibitor of angiogenesis
Ragini Kudchadkar et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Trypanosoma cruzi heparin-binding proteins and the nature of the host cell heparan sulfate-binding domain
Francisco Odenclo Rodrigues de Oliveira et al.
MICROBIAL PATHOGENESIS (2008)
Surfen, a small molecule antagonist of heparan sulfate
Manuela Schuksz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding
Katja Moelleken et al.
MOLECULAR MICROBIOLOGY (2008)
Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1
Lot de Witte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans
Andreas Schulze et al.
HEPATOLOGY (2007)
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus
Hans-Christoph Selinka et al.
JOURNAL OF VIROLOGY (2007)
Interference in dengue virus adsorption and uncoating by carrageenans
Laura B. Talarico et al.
VIROLOGY (2007)
Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding
David A. Bateman et al.
BMC NEUROSCIENCE (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members
Jennifer M. MacArthur et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Heparin induced thrombocytopenia: diagnosis and management update
I. Ahmed et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors
Michele Basche et al.
CLINICAL CANCER RESEARCH (2006)
Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts
Vaibhav Tiwari et al.
JOURNAL OF VIROLOGY (2006)
Release of sequestered malaria parasites upon injection of a glycosaminoglycan
Anna M. Vogt et al.
PLOS PATHOGENS (2006)
Interactions between heparan sulfate and proteins: the concept of specificity
Johan Kreuger et al.
JOURNAL OF CELL BIOLOGY (2006)
The biological relevance of chemokine-proteoglycan interactions
A. E. I. Proudfoot
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Microarrays of synthetic heparin oligosaccharides
JL de Paz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Inhibitory effect of heparan sulfate-like glycosaminoglycans on the infectivity of Chlamydia pneumoniae in HL cells varies between strains
Ying Yan et al.
MICROBES AND INFECTION (2006)
Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2
XB Ai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Polycationic calix[8]arenes able to recognize and neutralize heparin
Tommaso Mecca et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2006)
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: A double-blind placebo-controlled trial
MJ Keller et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses
E Lee et al.
ANTIVIRAL RESEARCH (2006)
Enzymatic redesigning of biologically active heparan sulfate
JH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ability of the heparan sulfate proteoglycan syndecan-1 to participate in bacterial translocation across the intestinal epithelial barrier
MJ Henry-Stanley et al.
SHOCK (2005)
Cell surface heparan sulfate promotes replication of Toxoplasma gondii
JR Bishop et al.
INFECTION AND IMMUNITY (2005)
Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C
Y Ishibashi et al.
HEPATOLOGY RESEARCH (2005)
Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans
C Noti et al.
CHEMISTRY & BIOLOGY (2005)
Heparan sulphate proteoglycans:: The sweet side of development
U Häcker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site
RR Vivès et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis
JP Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Heparan sulfate is a cellular receptor for purified infectious prions
L Horonchik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting
A Naggi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural basis for fibroblast growth factor receptor activation
M Mohammadi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
The design and evaluation of heparin-binding foldamers
S Choi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load
N Hirashima et al.
HEPATOLOGY RESEARCH (2004)
QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis
SW Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Low- and ultra-low-molecular-weight heparins
AK Kakkar
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides
C Thanawiroon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface
JH Andersen et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus
K Nyberg et al.
ANTIVIRAL RESEARCH (2004)
Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread
N Cheshenko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Lactoferrin - a multifunctional protein with antimicrobial properties
S Farnaud et al.
MOLECULAR IMMUNOLOGY (2003)
Cellular heparan sulfate participates in the metabolism of prions
O Ben-Zaken et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders
J van Horssen et al.
LANCET NEUROLOGY (2003)
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer
JP Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families
M Schmidtke et al.
VIROLOGY (2003)
The role of selectins in inflammation and disease
K Ley
TRENDS IN MOLECULAR MEDICINE (2003)
Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells
IM Frick et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
CA Sherman-Baust et al.
CANCER CELL (2003)
Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1α domain of PfEMP1
AM Vogt et al.
BLOOD (2003)
Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans
M Morimoto-Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synthesis, cytotoxicity and antiviral activity of N,N′-bis-5-nitropyrimidyl derivatives of dispirotripiperazine
M Schmidtke et al.
ANTIVIRAL RESEARCH (2002)
Roles of heparan-sulphate glycosaminoglycans in cancer
R Sasisekharan et al.
NATURE REVIEWS CANCER (2002)
Identification of the heparan sulfate binding sites in the cellular prion protein
RG Warner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: Tubulin-dependent rearrangements
U Brockstedt et al.
EXPERIMENTAL CELL RESEARCH (2002)
Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro
JA Cohlberg et al.
BIOCHEMISTRY (2002)
Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis
DF Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A dose-determining trial of heparinase-I (Neutralase™) for heparin neutralization in coronary artery surgery
EK Heres et al.
ANESTHESIA AND ANALGESIA (2001)
Heparan sulfate proteoglycans and cancer
FH Blackhall et al.
BRITISH JOURNAL OF CANCER (2001)
Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase
GK Dhoot et al.
SCIENCE (2001)
Chemokines in pathology and medicine
M Baggiolini
JOURNAL OF INTERNAL MEDICINE (2001)
The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for Plasmodium sporozoite attachment to target cells
C Pinzon-Ortiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae
FN Wuppermann et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence
PW Park et al.
NATURE (2001)
Human papillomavirus infection requires cell surface heparan sulfate
T Giroglou et al.
JOURNAL OF VIROLOGY (2001)
Heparin and heparan sulfate: biosynthesis, structure and function
R Sasisekharan et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2000)
Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome)
AL Sertié et al.
HUMAN MOLECULAR GENETICS (2000)
Histidine 295 and histidine 510 are crucial for the enzymatic degradation of heparan sulfate by heparinase III
K Pojasek et al.
BIOCHEMISTRY (2000)
Poly(sodium 4-styrene sulfonate): An effective candidate topical antimicrobial for the prevention of sexually transmitted diseases
BC Herold et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Syndecan-1 and syndecan-4 can mediate the invasion of OpaHSPG-expressing Neisseria gonorrhoeae into epithelial cells
E Freissler et al.
CELLULAR MICROBIOLOGY (2000)
分享论文
